Израиль - английский - Ministry of Health

inovamed pharma ltd, israel - carbidopa; entacapone; levodopa - film coated tablets - levodopa 50 mg; carbidopa 12.5 mg; entacapone 200 mg - levodopa and decarboxylase inhibitor - levodopa and decarboxylase inhibitor - treatment of patients with parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (ddc) inhibitor treatment.

Израиль - английский - Ministry of Health

inovamed pharma ltd, israel - carbidopa; entacapone; levodopa - film coated tablets - levodopa 150 mg; carbidopa 37.5 mg; entacapone 200 mg - levodopa and decarboxylase inhibitor - levodopa and decarboxylase inhibitor - treatment of patients with parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (ddc) inhibitor treatment.

Израиль - английский - Ministry of Health

inovamed pharma ltd, israel - carbidopa as monohydrate; entacapone; levodopa - film coated tablets - levodopa 125 mg; entacapone 200 mg; carbidopa as monohydrate 31.25 mg - levodopa - levodopa - treatment of patients with parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa/decarboxylase (ddc) inhibitor treatment.

Европейский союз - английский - EMA (European Medicines Agency)

orion corporation - entacapone - parkinson disease - anti-parkinson drugs - entacapone is indicated as an adjunct to standard preparations of levodopa / benserazide or levodopa / carbidopa for use in adult patients with parkinson's disease and end-of-dose motor fluctuations, who cannot be stabilised on those combinations.

Европейский союз - английский - EMA (European Medicines Agency)

teva pharma b.v. - entacapone - parkinson disease - anti-parkinson drugs - entacapone is indicated as an adjunct to standard preparations of levodopa / benserazide or levodopa / carbidopa for use in adult patients with parkinson's disease and end-of-dose motor fluctuations, who cannot be stabilised on those combinations.

Австралия - английский - Department of Health (Therapeutic Goods Administration)

abbvie pty ltd - carbidopa monohydrate, quantity: 5 mg/ml; levodopa, quantity: 20 mg/ml - gel - excipient ingredients: purified water; carmellose sodium - for the treatment of advanced idiopathic parkinson?s disease with severe motor fluctuations despite optimised alternative pharmacological treatment.

Канада - английский - Health Canada

sandoz canada incorporated - entacapone; carbidopa; levodopa - tablet - 200mg; 12.5mg; 50mg - entacapone 200mg; carbidopa 12.5mg; levodopa 50mg - catechol-o-methyltransferase (comt) inhibitors

Канада - английский - Health Canada

sandoz canada incorporated - entacapone; carbidopa; levodopa - tablet - 200mg; 31.25mg; 125mg - entacapone 200mg; carbidopa 31.25mg; levodopa 125mg - catechol-o-methyltransferase (comt) inhibitors

Канада - английский - Health Canada

sandoz canada incorporated - entacapone; carbidopa; levodopa - tablet - 200mg; 18.75mg; 75mg - entacapone 200mg; carbidopa 18.75mg; levodopa 75mg - catechol-o-methyltransferase (comt) inhibitors

Канада - английский - Health Canada

sandoz canada incorporated - entacapone; carbidopa; levodopa - tablet - 200mg; 37.5mg; 150mg - entacapone 200mg; carbidopa 37.5mg; levodopa 150mg - catechol-o-methyltransferase (comt) inhibitors